Cargando…
Current treatment options for the management of esophageal cancer
In recent years, esophageal cancer characteristics and management options have evolved significantly. There has been a sharp increase in the frequency of esophageal adenocarcinoma and a decline in the frequency of squamous cell carcinoma. A more comprehensive understanding of prognostic factors infl...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496368/ https://www.ncbi.nlm.nih.gov/pubmed/23152702 http://dx.doi.org/10.2147/CMAR.S27593 |
_version_ | 1782249620872626176 |
---|---|
author | Mawhinney, Mark R Glasgow, Robert E |
author_facet | Mawhinney, Mark R Glasgow, Robert E |
author_sort | Mawhinney, Mark R |
collection | PubMed |
description | In recent years, esophageal cancer characteristics and management options have evolved significantly. There has been a sharp increase in the frequency of esophageal adenocarcinoma and a decline in the frequency of squamous cell carcinoma. A more comprehensive understanding of prognostic factors influencing outcome has also been developed. This has led to more management options for esophageal cancer at all stages than ever before. A multidisciplinary, team approach to management in a high volume center is the preferred approach. Each patient should be individually assessed based on type of cancer, local or regional involvement, and his or her own functional status to determine an appropriate treatment regimen. This review will discuss management of esophageal cancer relative to disease progression and patient functional status. |
format | Online Article Text |
id | pubmed-3496368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-34963682012-11-14 Current treatment options for the management of esophageal cancer Mawhinney, Mark R Glasgow, Robert E Cancer Manag Res Review In recent years, esophageal cancer characteristics and management options have evolved significantly. There has been a sharp increase in the frequency of esophageal adenocarcinoma and a decline in the frequency of squamous cell carcinoma. A more comprehensive understanding of prognostic factors influencing outcome has also been developed. This has led to more management options for esophageal cancer at all stages than ever before. A multidisciplinary, team approach to management in a high volume center is the preferred approach. Each patient should be individually assessed based on type of cancer, local or regional involvement, and his or her own functional status to determine an appropriate treatment regimen. This review will discuss management of esophageal cancer relative to disease progression and patient functional status. Dove Medical Press 2012-11-02 /pmc/articles/PMC3496368/ /pubmed/23152702 http://dx.doi.org/10.2147/CMAR.S27593 Text en © 2012 Mawhinney and Glasgow, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Review Mawhinney, Mark R Glasgow, Robert E Current treatment options for the management of esophageal cancer |
title | Current treatment options for the management of esophageal cancer |
title_full | Current treatment options for the management of esophageal cancer |
title_fullStr | Current treatment options for the management of esophageal cancer |
title_full_unstemmed | Current treatment options for the management of esophageal cancer |
title_short | Current treatment options for the management of esophageal cancer |
title_sort | current treatment options for the management of esophageal cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496368/ https://www.ncbi.nlm.nih.gov/pubmed/23152702 http://dx.doi.org/10.2147/CMAR.S27593 |
work_keys_str_mv | AT mawhinneymarkr currenttreatmentoptionsforthemanagementofesophagealcancer AT glasgowroberte currenttreatmentoptionsforthemanagementofesophagealcancer |